Topics:
Cardiology • Peripheral Vascular Disease
Based on results from the VOYAGER PAD trial, when would you consider the primary use of rivaroxaban with aspirin +/- clopidogrel as opposed to conventional aspirin +/- clopidogrel in patients undergoing lower extremity revascularization?
Answer from: at Community Practice
Based on the results of the VOYAGER PAD trial, I would consider using rivaroxaban with ASA before undergoing revascularization.
Sign in or Register to read more